✦ LIBER ✦

Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies

✍ Scribed by M. Wasif Saif; F. Lansigan; S. Ruta; L. Lamb; M. Mezes; K. Elligers; N. Grant; Z.-L. Jiang; S.H. Liu; Y.-C. Cheng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-in-human phase II trial of the bot

✍ Saif, Muhammad Wasif; Li, Jia; Lamb, Lynne; Kaley, Kristin; Elligers, Kyle; Jian 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 477 KB

Phase I combination study of trabectedin

✍ Lia Gore, E. Rivera, M. Basche, S. L. Moulder-Thompson, J. Li, S. Eppers, S. Gro 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 159 KB

Phase I and pharmacokinetic study of cap

✍ Maarten J. Deenen, Heinz-Josef Klümpen, Dick J. Richel, Rolf W. Sparidans, Marie 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 299 KB

Phase I dose escalation study of capecit

✍ Jiang, Yixing; Mackley, Heath B.; Kimchi, Eric T.; Zhu, Junjia; Gusani, Niraj; K 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 256 KB

402 POSTER A phase I study of gemcitabin

✍ S. Leong; C.L. Obryant; W.A. Messersmith; S. Diab; M.A. Kane; S. Nallapreddy; C. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Phase I study of weekly (day 1 and 8) do

✍ Ramesh K. Ramanathan; Sakkaraiappan Ramalingam; Merrill J. Egorin; Chandra P. Be 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 227 KB